在患有早期神经障碍的老年时的社会参与:描述性定性研究的协议
Mia Lapointe1,2, Megan Veilleux1,2, Pascale Simard1,2
1School of Rehabilitation Sciences, Faculty of Medicine, Laval University, Québec, QC, Canada.
JMIR research protocols
|August 6, 2025
概括
患有创伤性脑损伤 (TBI),多发性硬化症 (MS) 或脊髓损伤 (SCI) 的老年人经历了多样化的社会参与. 了解这些经验和障碍是制定支持性健康计划的关键.
科学领域:
- 老年学是指老年学的学科.
- 神经学 神经学
- 康复科学 康复科学 康复科学
背景情况:
- 患有创伤性脑损伤 (TBI),多发性硬化症 (MS) 和脊髓损伤 (SCI) 的老龄化人口需要适应的健康和社会服务.
- 社会参与对于积极老龄化和健康至关重要,但对神经障碍老龄化人口的证据有限.
- 了解各种社会参与体验对于开发包容性健康促进方法至关重要.
研究的目的:
- 探索TBI,MS或SCI老龄化个体的社会参与经验.
- 识别影响其社会参与的障碍和促进者.
- 探索加强社会参与的干预策略.
主要方法:
- 在行动研究框架内进行描述性的定性研究.
- 半结构面试与24名50岁以上的参与者 (每人有8名TBI,MS,SCI) 进行.
- 使用框架方法进行分析,结合归纳主题和人类发展-残疾创造过程模型.
主要成果:
- 洞察神经障碍老年人的各种社会参与体验.
- 了解个人特征和环境因素对社会参与的影响.
- 确定具体的挑战和促进社会参与的因素.
结论:
- 为共同开发健康促进计划为神经障碍老年人群的社会参与奠定基础.
- 确定促进社会参与的资源和优势.
- 突出需要干预以改善社会包容性的系统性障碍.
关键词:
在MSMSMSMSMSMSMSMSMSMSMS中,我们可以看到我们的SCI和SCI.这是一个TBI,TBI.积极和健康的老龄化衰老的衰老 衰老的衰老年长的年长的年长的年长的年长年长的老人老年人老年人.老年病的治疗方法老年病学 老年病学是一门学科.个体老龄化与残疾的个人.多发性硬化症多发性硬化症这是一个神经神经神经神经.神经系统疾病 神经系统疾病神经障碍是指神经系统上的残疾.神经系统疾病 神经系统疾病神经系统疾病 神经系统疾病神经学家是神经学家.神经科学 神经科学年龄较大的成年人.老年人年长的人.老年人是一个老人.社会参与 参与社会参与脊髓损伤导致的脊髓损伤创伤性脑损伤是一种创伤性脑损伤.更多相关视频
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.8K
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.3K
相关概念视频
Intellectual Disability
159
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
159
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
